Lobbying client
ALLACCEM INC
Use of nanotechnology to develop new chemical formulations for medical uses
Filings
3
Filed by
1
Reported in-house
—
Reported by firms
$20,000
Filings
3 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
Year-End Termination Year-End 2007
|
DONALD MASSEY | — reported |
|
Mid-Year Report Mid-Year 2007
|
DONALD MASSEY | $20,000 reported |
|
Registration Mid-Year 2007
|
DONALD MASSEY | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| DONALD MASSEY | 2 | $20,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Defense | DEF | 3 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
| Bill | Congress | Times named |
|---|---|---|
| H.R. 3222 | 110th | 2 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.